This website uses cookies to enhance the user experience.
||
B

BIOVIVOTECH AS994 974 610

Research
Limited company
Sjøgata 21 8006 BODØ, Norge
Services
/ Research
/ 72.110 Research and experimental development on biotechnology

BIOVIVOTECH AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO
KK

Kjetil Korsnes1970

Chairman of the board
CH

Cato Helstrøm1951

Years since formation
15 years
since Jan 11, 2010
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
300,000
1 share class
Total number of shareholders
2
persons

Financials

Total operating income 2024
2,748,222
NOK
Annual total result 2024
590,807
NOK
Total equity 2024
1,283,111
NOK
Last update: Jul 21, 2025

Management

Management / administration

NameRoleShares
KK

Kjetil Korsnes

1970

Managing Director/CEO
50 %
directly

Board

NameRoleShares
CH

Cato Helstrøm

1951

Chairman-
KK

Kjetil Korsnes

1970

Board Member
50 %
directly
IL

Inger Lene Wassmo

1968

Board Member
50 %
directly
CM

Christopher Marlowe Arandela Caipang

1972

Alternate Member-

Others

NameRoleShares
E
EVER AS
Accountant-

Top 10 individual shareholders

NameRoleShares
IL

Inger Lene Wassmo

1968

Board Member
50 %
directly
KK

Kjetil Korsnes

1970

Managing Director/CEO, Board Member
50 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
IL

Inger Lene Wassmo

1968

Ordinary shares
150,000
50 %
KK

Kjetil Korsnes

1970

Ordinary shares
150,000
50 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
2,748,222
3,195,940
2,466,061
3,841,300
Annual Total Result
590,807
216,854
154,081
109,233
Total assets
3,174,844
2,900,975
3,012,395
2,785,508
Total liabilities
1,891,733
2,208,671
2,536,945
2,464,140
Total equity
1,283,111
692,304
475,450
321,369

P&L

Year2024202320222021
Total operating income
2,748,222
3,195,940
2,466,061
3,841,300
Total operating costs
2,154,305
2,957,526
2,308,953
3,713,002
Operating result
593,917
238,414
157,108
128,297
Financial income/costs
-3,110
-21,560
-3,027
-19,065
Profit before tax
590,807
216,854
154,081
109,233
Total tax & extraordinary income/cost
0
0
0
0
Annual Total Result
590,807
216,854
154,081
109,233

Balance overview

Year2024202320222021
Total fixed assets
143,161
192,470
20,643
39,699
Total current assets
3,031,683
2,708,504
2,991,751
2,745,810
Total assets
3,174,844
2,900,975
3,012,395
2,785,508
Short term debt
1,236,952
1,539,771
2,045,399
1,981,127
Long term debt
654,781
668,901
491,546
483,012
Total liabilities
1,891,733
2,208,671
2,536,945
2,464,140
Contributed capital
1,550,000
1,550,000
1,550,000
1,550,000
Retained earnings
-266,889
-857,696
-1,074,550
-1,228,631
Total equity
1,283,111
692,304
475,450
321,369
Total equity and liabilities
3,174,844
2,900,975
3,012,395
2,785,508

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology